Zim Laboratories Limited has submitted a regulatory intimation to BSE Limited and National Stock Exchange of India Limited regarding an upcoming board meeting.
The Board of Directors meeting is scheduled for Wednesday, 04th November 2026. The primary agenda is to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended 30th September 2026.
In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Insider Trading, the trading window for dealing in the company's securities remains closed. The closure period is from Thursday, 01st October 2026 to Friday, 06th November 2026 (both days inclusive).
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication is signed by Piyush Siddheshwar Nikhade, Company Secretary and Compliance Officer (Membership No. A38972), on behalf of Zim Laboratories Limited.
Financial Impact
Financial impact not quantified in the disclosure. The announcement serves as advance intimation of the upcoming board meeting and results announcement.